Maddie's Match is BACK!
Join us Sunday 13 August at Marvel Stadium at 3.20 pm.
Together, we can Fight Like Maddie for people living with Bone Marrow Failure Syndromes.
Maddie Riewoldt was just 26 years old when she tragically died of a Bone Marrow Failure Syndrome called Aplastic Anaemia. When her fight was ending in February 2015, she asked her family to make her a promise; Maddie wanted nobody else to go through what she did.
Maddie Riewoldt’s Vision is her legacy.
Every 3 days an Australian is diagnosed with a Bone Marrow Failure Syndromes. Distressingly, most of them are children and young adults, and 50% will not survive. Thousands more are living with ongoing complex health issues.
At Maddie’s Vision, we are determined to find better support options, treatments and a cure for patients living with Bone Marrow Failure Syndromes and their families. Please join us and together, we will #FightLikeMaddie.
Help us find a cure for Bone Marrow Failure Syndromes
How you've helped us make a difference
The first Maddie’s Match in 2015 funded our very first medical research project. Since then, with the support of the incredible football community, we've made a huge impact:
36 cutting-edge esearch projects funded
81 patients supported through our national Telehealth Nurse service
$8.7 million committed to research, with an additional $14 million further raised by our grantees and fellows through leveraged funding
2 clincial trials, resulting in faster diagnosis for patients and access to more holistic treatment and care.
About Bone Marrow Failure Syndromes
Bone Marrow Failure Syndromes are a collection of medical conditions where the bone marrow stops working or works insufficiently.
This means that bone marrow stem cells can’t produce enough healthy red blood cells, white blood cells and platelets to meet the body’s daily requirements. When a person’s bone marrow no longer works adequately, they become extremely sick
About Maddie Riewoldt's Vision
Formed in June 2015 by the Riewoldt family, Maddie Riewoldt’s Vision funds vital research to accelerate new treatments for Bone Marrow Failure Syndromes, while providing support, guidance and resources to patients and their families.